Implementation and Outcome of Minimally Invasive Pancreatoduodenectomy in Europe: A Critical Appraisal of the First 3 Years of the E-MIPS Registry
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,336
- 试验地点
- 1
- 主要终点
- 30-day/in-hospital mortality.
研究概览
简要总结
A planned analysis of outcomes among consecutive patients after MIPD from centers participating in the E-MIPS registry (2019-2021). Main outcomes of interest were major morbidity (Clavien-Dindo grade ≥3) and 30-day/in-hospital mortality.
详细描述
The European registry for Minimally Invasive Pancreatic Surgery (E-MIPS) is an E-AHPBA endorsed registry with the aim to monitor and safeguard the introduction of MIPD in Europe. International multicenter audit-based studies focusing on outcomes of minimally invasive pancreatoduodenectomy (MIPD) are lacking.
A planned analysis of outcomes among consecutive patients after MIPD from centers participating in the E-MIPS registry (2019-2021). Main outcomes of interest were major morbidity (Clavien-Dindo grade ≥3) and 30-day/in-hospital mortality.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Data from all patients who underwent R-MIPD and L-MIPD between January 1st 2019 and December 31st 2021 were included
排除标准
- •Other pancreatic procedures
- •Hybrid approaches (reconstruction phase open)
- •Procedures with insufficient baseline data / missing primary outcome data.
结局指标
主要结局
30-day/in-hospital mortality.
时间窗: 30 days
Major morbidity
时间窗: 30 days
次要结局
未报告次要终点
研究者
M.G. Besselink
professor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)